Serum Glial Fibrillary Acidic Protein: A Surrogate Marker of the Activity of Multiple Sclerosis
Open Access
- 1 January 2020
- journal article
- research article
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 35 (3) , 212-218
Abstract
Multiple sclerosis (MS) is a neurodegenerative disorder with various clinical types. Glial fibrillary acidic protein (GFAP) is significantly elevated in the cerebrospinal fluid (CSF) of MS patients compared with that of healthy controls. The aim of this study is to evaluate serum levels of GFAP in relation to disease activity in relapsing-remitting MS patients and to compare them with those of healthy controls. This study involved 58 MS patients of relapsing-remitting MS (RRMS) type, 22 in an active stage of the disease and 36 in remission, and 50 healthy individuals as age- and sex-matched controls. Blood samples were taken from the patients at the MS Clinic of the Baghdad Teaching Hospital, and the serum levels of GFAP were determined using the enzyme-linked immunosorbent assay (ELISA) technique. Mean GFAP serum levels in 22 patients presenting in the active state of the disease (6.47±3.39 ng/ml) and 36 cases in remission were (5.33±2.82 ng/ml) (p=0.074) were determined as indicated. When RRMS patients (n=58) were compared with the healthy controls (n=50, 1.89±1.21), the difference in serum levels of GFAP was statistically significant (p<0.001). The area under the curve of the serum measures of GFAP obtained through the receiver operating characteristics was 0.903, which was also statistically significant (p<0.001). GFAP biomarker is an indicator of disease activity in RRMS patients, and its serum level may correlate with the state of remission or exacerbation.Keywords
This publication has 26 references indexed in Scilit:
- Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage markerJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Glial and Axonal Body Fluid Biomarkers Are Related to Infarct Volume, Severity, and OutcomeJournal of Stroke and Cerebrovascular Diseases, 2008
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?Annual Review of Neuroscience, 2008
- The integrity of the blood?brain barrier in Alzheimer?s diseaseActa Neurologica Scandinavica, 2007
- Cerebrospinal Fluid Analysis in Multiple Sclerosis2007
- Microglia and multiple sclerosisJournal of Neuroscience Research, 2005
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Neuronal modulation of schwann cell glial fibrillary acidic protein (GFAP)Journal of Neuroscience Research, 1989
- Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosisNeurology, 1977
- An acidic protein isolated from fibrous astrocytesBrain Research, 1971